Huilai Zhang

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 20

Top Topics

Diffuse Large B Cell Lymphoma

Prognostic Factors

Patient Reported Outcomes

Top Venues

Cancer biology & medicine

Hematological oncology

Journal of immunology research

This page only lists publications with an associated author ORCID identifier.

Publications

Xiaohui Wang, Hengqi Liu, Yue Fei, Zheng Song, Xiangrui Meng, Jingwei Yu, Xia Liu, Lanfang Li, Lihua Qiu, Zhengzi Qian, Shiyong Zhou, Xianhuo Wang, Huilai Zhang
Metabolic pathway-based subtyping reveals distinct microenvironmental states associated with diffuse large B-cell lymphoma outcomes. Hematological oncology 42 (4) (2024)
Zegeng Chen, He Huang, Huageng Huang, Le Yu, Huawei Weng, Jian Xiao, Liqun Zou, Huilai Zhang, Chaoyong Liang, Hui Zhou, Hongqiang Guo, Zhao Wang, Zhi-Ming Li, Tao Wu, Hongyu Zhang, Huijing Wu, Zhigang Peng, Linzhu Zhai, Xinggui Chen, Zhi-Wei Liang, Huangming Hong, Tongyu Lin
Genomic features reveal potential benefit of adding anti-PD-1 immunotherapy to treat non-upper aerodigestive tract natural killer/T-cell lymphoma. Leukemia 38 (4) (2024)
Zegeng Chen, He Huang, Huageng Huang, Le Yu, Huawei Weng, Jian Xiao, Liqun Zou, Huilai Zhang, Chaoyong Liang, Hui Zhou, Hongqiang Guo, Zhao Wang, Zhi-Ming Li, Tao Wu, Hongyu Zhang, Huijing Wu, Zhigang Peng, Linzhu Zhai, Xinggui Chen, Zhi-Wei Liang, Huangming Hong, Tongyu Lin
Genomic features reveal potential benefit of adding anti-PD-1 immunotherapy to treat non-upper aerodigestive tract natural killer/T-cell lymphoma. Leukemia (2024)
Sicong Zhang, Xianming Liu, Lanfang Li, Lihua Qiu, Zhengzi Qian, Shiyong Zhou, Xianhuo Wang, Huilai Zhang
Hodgkin's lymphoma: 2023 update on treatment. Cancer biology & medicine 21 (4) (2024)
Zegeng Chen, He Huang, Huageng Huang, Le Yu, Huawei Weng, Jian Xiao, Liqun Zou, Huilai Zhang, Chaoyong Liang, Hui Zhou, Hongqiang Guo, Zhao Wang, Zhi-Ming Li, Tao Wu, Hongyu Zhang, Huijing Wu, Zhigang Peng, Linzhu Zhai, Xinggui Chen, Zhi-Wei Liang, Huangming Hong, Tongyu Lin
Genomic features reveal potential benefit of adding anti-PD-1 immunotherapy to treat non-upper aerodigestive tract natural killer/T-cell lymphoma. Leukemia 38 (4) (2024)
Sicong Zhang, Xianming Liu, Lanfang Li, Lihua Qiu, Zhengzi Qian, Shiyong Zhou, Xianhuo Wang, Huilai Zhang
Hodgkin's lymphoma: 2023 update on treatment. Cancer biology & medicine 21 (4) (2024)
Zegeng Chen, He Huang, Huageng Huang, Le Yu, Huawei Weng, Jian Xiao, Liqun Zou, Huilai Zhang, Chaoyong Liang, Hui Zhou, Hongqiang Guo, Zhao Wang, Zhi-Ming Li, Tao Wu, Hongyu Zhang, Huijing Wu, Zhigang Peng, Linzhu Zhai, Xinggui Chen, Zhi-Wei Liang, Huangming Hong, Tongyu Lin
Genomic features reveal potential benefit of adding anti-PD-1 immunotherapy to treat non-upper aerodigestive tract natural killer/T-cell lymphoma. Leukemia 38 (4) (2024)
Sicong Zhang, Xianming Liu, Lanfang Li, Lihua Qiu, Zhengzi Qian, Shiyong Zhou, Xianhuo Wang, Huilai Zhang
Hodgkin's lymphoma: 2023 update on treatment. Cancer biology & medicine 21 (4) (2024)
Sicong Zhang, Xianming Liu, Lanfang Li, Lihua Qiu, Zhengzi Qian, Shiyong Zhou, Xianhuo Wang, Huilai Zhang
Hodgkin's lymphoma: 2023 update on treatment. Cancer biology & medicine (2023)
Weicheng Ren, Hui Wan, Sulaf Abd Own, Mattias Berglund, Xianhuo Wang, Mingyu Yang, Xiaobo Li, Dong-Bing Liu, Xiaofei Ye, Kristina Sonnevi, Gunilla Enblad, Rose-Marie Amini, Birgitta Sander, Kui Wu, Huilai Zhang, Björn Engelbrekt Wahlin, Karin E Smedby, Qiang Pan-Hammarström
Genetic and transcriptomic analyses of diffuse large B-cell lymphoma patients with poor outcomes within two years of diagnosis. Leukemia 38 (3) (2023)
Weicheng Ren, Hui Wan, Sulaf Abd Own, Mattias Berglund, Xianhuo Wang, Mingyu Yang, Xiaobo Li, Dong-Bing Liu, Xiaofei Ye, Kristina Sonnevi, Gunilla Enblad, Rose-Marie Amini, Birgitta Sander, Kui Wu, Huilai Zhang, Björn Engelbrekt Wahlin, Karin E Smedby, Qiang Pan-Hammarström
Genetic and transcriptomic analyses of diffuse large B-cell lymphoma patients with poor outcomes within two years of diagnosis. Leukemia 38 (3) (2023)
Weicheng Ren, Hui Wan, Sulaf Abd Own, Mattias Berglund, Xianhuo Wang, Mingyu Yang, Xiaobo Li, Dong-Bing Liu, Xiaofei Ye, Kristina Sonnevi, Gunilla Enblad, Rose-Marie Amini, Birgitta Sander, Kui Wu, Huilai Zhang, Björn Engelbrekt Wahlin, Karin E Smedby, Qiang Pan-Hammarström
Genetic and transcriptomic analyses of diffuse large B-cell lymphoma patients with poor outcomes within two years of diagnosis. Leukemia 38 (3) (2023)
Weicheng Ren, Hui Wan, Sulaf Abd Own, Mattias Berglund, Xianhuo Wang, Mingyu Yang, Xiaobo Li, Dong-Bing Liu, Xiaofei Ye, Kristina Sonnevi, Gunilla Enblad, Rose-Marie Amini, Birgitta Sander, Kui Wu, Huilai Zhang, Björn Engelbrekt Wahlin, Karin E Smedby, Qiang Pan-Hammarström
Genetic and transcriptomic analyses of diffuse large B-cell lymphoma patients with poor outcomes within two years of diagnosis. Leukemia 38 (3) (2023)
Weicheng Ren, Hui Wan, Sulaf Abd Own, Mattias Berglund, Xianhuo Wang, Mingyu Yang, Xiaobo Li, Dong-Bing Liu, Xiaofei Ye, Kristina Sonnevi, Gunilla Enblad, Rose-Marie Amini, Birgitta Sander, Kui Wu, Huilai Zhang, Björn Engelbrekt Wahlin, Karin E Smedby, Qiang Pan-Hammarström
Genetic and transcriptomic analyses of diffuse large B-cell lymphoma patients with poor outcomes within two years of diagnosis. Leukemia 38 (3) (2023)
Weicheng Ren, Hui Wan, Sulaf Abd Own, Mattias Berglund, Xianhuo Wang, Mingyu Yang, Xiaobo Li, Dong-Bing Liu, Xiaofei Ye, Kristina Sonnevi, Gunilla Enblad, Rose-Marie Amini, Birgitta Sander, Kui Wu, Huilai Zhang, Björn Engelbrekt Wahlin, Karin E Smedby, Qiang Pan-Hammarström
Genetic and transcriptomic analyses of diffuse large B-cell lymphoma patients with poor outcomes within two years of diagnosis. Leukemia 38 (3) (2023)
Weicheng Ren, Hui Wan, Sulaf Abd Own, Mattias Berglund, Xianhuo Wang, Mingyu Yang, Xiaobo Li, Dong-Bing Liu, Xiaofei Ye, Kristina Sonnevi, Gunilla Enblad, Rose-Marie Amini, Birgitta Sander, Kui Wu, Huilai Zhang, Björn Engelbrekt Wahlin, Karin E Smedby, Qiang Pan-Hammarström
Genetic and transcriptomic analyses of diffuse large B-cell lymphoma patients with poor outcomes within two years of diagnosis. Leukemia (2023)
Zhenjie Qu, Tingting Zhang, Fenghua Gao, Wenchen Gong, Yaoli Cui, Lihua Qiu, Zhengzi Qian, Shiyong Zhou, Bin Meng, Xiubao Ren, Lanfang Li, Xianhuo Wang, Huilai Zhang
Screening of Adverse Prognostic Factors and Construction of Prognostic Index in Previously Untreated Concurrent Follicular Lymphoma and Diffuse Large B-Cell Lymphoma. BioMed research international 2022 (2022)
Huijuan Lv, Yue Fei, Wei Li, Yi Wang, Jinni Wang, Jin He, Xianming Liu, Lanfang Li, Lihua Qiu, Zhengzi Qian, Shiyong Zhou, Bin Meng, Qiongli Zhai, Xiubao Ren, Dehui Zou, Qing-Qing Cai, Xianhuo Wang, Huilai Zhang
A novel clinical immune-related prognostic model predicts the overall survival of mantle cell lymphoma. Hematological oncology 40 (3) (2022)
Mingxiao Lang, Youqin Feng, Xiangrui Meng, Jing Zhao, Zheng Song, Zhengzi Qian, Lihua Qiu, Shiyong Zhou, Xianming Liu, Lanfang Li, Haiyan Yang, Yuqin Song, Wei Li, Huilai Zhang
Improved method to stratify lymphoma patients with risk of secondary central nervous system involvement: A multicenter retrospective analysis. Hematological oncology (2021)
Tingting Zhang, Tianyuan Ren, Zheng Song, Jing Zhao, Lei Jiao, Zhenzhen Zhang, Jin He, Xianming Liu, Lihua Qiu, Lanfang Li, Shiyong Zhou, Bin Meng, Qiongli Zhai, Xiubao Ren, Zhengzi Qian, Xianhuo Wang, Huilai Zhang
Genetic Mutations of Tim-3 Ligand and Exhausted Tim-3+ CD8+ T Cells and Survival in Diffuse Large B Cell Lymphoma. Journal of immunology research 2020 (2020)